You have 9 free searches left this month | for more free features.

paroxysmal nocturnal hemoglobinuria (PNH)

Showing 1 - 25 of 1,414

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial (MY008211A tablets)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • MY008211A tablets
  • (no location specified)
Nov 17, 2023

PNH - Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074)

Not yet recruiting
  • PNH - Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Feb 13, 2023

Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Mar 17, 2023

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Brisbane (ADX-038, Placebo)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane
May 17, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in China (Eculizumab)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Beijing, China
  • +6 more
May 24, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial run by the Aplastic Anemia and MDS International Foundation

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
    • Bethesda, Maryland
      Aplastic Anemia and MDS International Foundation
    Feb 23, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial (HRS-5965 tablets)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • HRS-5965 tablets
    • (no location specified)
    Sep 20, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • (no location specified)
    Jan 17, 2023

    Paroxysmal Nocturnal Hemoglobinuria, PNH, Extravascular Hemolysis Trial (Danicopan)

    Available
    • Paroxysmal Nocturnal Hemoglobinuria
    • +2 more
    • (no location specified)
    Aug 1, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial in Tianjin (MY008211A tablets)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • MY008211A tablets
    • Tianjin, Tianjin, China
      Nstitute of Hematology & Blood Disease Hospital, Chinese Academy
    Sep 17, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074, Soliris)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • (no location specified)
    Jan 17, 2023

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Italy, United Kingdom, United States (Danicopan, Eculizumab)

    Active, not recruiting
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • Baltimore, Maryland
    • +4 more
    Aug 15, 2022

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
      • Boston, Massachusetts
        Contact the PNH Registry at Alexion Pharmaceuticals, Inc. for wo
      Dec 7, 2021

      Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Danicopan)

      Completed
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • Florence, Italy
      • +4 more
      May 31, 2022

      Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Hemoglobinuria Trial in Worldwide (Pegcetacoplan)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • Paroxysmal Hemoglobinuria
      • Atlanta, Georgia
      • +9 more
      Jul 18, 2022

      Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

      Recruiting
      • Severe Aplastic Anemia (SAA)
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 28, 2023

      Paroxysmal Nocturnal Hemoglobinuria, PNH Trial in Austria, South Africa, United Kingdom (BCX9930)

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • PNH
      • Vienna, Austria
      • +3 more
      Feb 15, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in China (Crovalimab)

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Changchun City, China
      • +5 more
      Jul 11, 2022

      Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (BCX9930 monotherapy, Placebo)

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • BCX9930 monotherapy
      • Placebo
      • Ampang, Malaysia
      • +3 more
      Dec 15, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Ravulizumab)

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Ravulizumab
      • Atlanta, Georgia
      • +8 more
      Aug 15, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial (Danicopan)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Baltimore, Maryland
      • +4 more
      Feb 1, 2023

      Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (BCX9930, Eculizumab, Ravulizumab)

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • Paris, France
      • +6 more
      Dec 15, 2022

      Paroxysmal Nocturnal Hemoglobinuria, PNH Trial in Worldwide (Ravulizumab)

      Completed
      • Paroxysmal Nocturnal Hemoglobinuria
      • PNH
      • Ravulizumab
      • Toronto, Ontario, Canada
      • +15 more
      Dec 7, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in China (KP104)

      Not yet recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Beijing, China
      • +3 more
      Jul 25, 2022

      Paroxysmal Nocturnal Hemoglobinuria (PNH), CD55-deficient Protein-losing Enteropathy (PLE), CD59 Deficiency Trial (Pozelimab)

      Available
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • +2 more
      • (no location specified)
      Jan 28, 2022